Molecules that reduce 'bad' gut bacteria reverse narrowing of arteries
in animal study
Promoting a healthy gut microbiome may be a powerful strategy for
lowering cholesterol and other heart attack risk factors

Date:
June 15, 2020
Source:
Scripps Research Institute
Summary:
Scientists have developed molecules that can remodel the bacterial
population of intestines to a healthier state. They also have shown
- - through experiments in mice -- that this approach reduces
cholesterol levels and strongly inhibits the thickened-artery
condition known as atherosclerosis.



FULL STORY ========================================================================== Scientists at Scripps Research have developed molecules that can remodel
the bacterial population of intestines to a healthier state and they have
shown - - through experiments in mice -- that this reduces cholesterol
levels and strongly inhibits the thickened-artery condition known as atherosclerosis.


==========================================================================
The scientists, who report their findings in Nature Biotechnology,
created a set of molecules called peptides that can slow the growth
of less-desirable species of gut bacteria. In mice that develop high cholesterol and atherosclerosis from a high-fat diet, the peptides
beneficially shifted the balance of species in the gut microbiome,
which refers to the trillions of bacteria that live inside the digestive system. This shift reduced cholesterol levels and dramatically slowed
the buildup of fatty deposits in arteries - - symptoms that are the
hallmarks of atherosclerosis.

Atherosclerosis is the condition that leads to heart attacks and strokes,
the two leading causes of death among humans.

"It was surprising to us that simply remodeling the gut microbiome can
have such an extensive effect," says study co-senior author Reza Ghadiri,
PhD, professor in the Department of Chemistry at Scripps Research.

Gut microbes shape our health The gut microbiome, which includes hundreds
of bacterial species, evolved long ago as part of a fundamental symbiosis:
The bacteria get a place to live and plenty to eat, and in return they
assist their animal hosts, largely by helping them digest food.



==========================================================================
In the past two decades, these symbiotic bacteria have become a focus of intense study around the world, as scientists have discovered that the
microbes -- in part by their production of molecules called metabolites
-- not only help digest food, but play a role in metabolism, immunity
and other important functions.

Scientists also have learned that this symbiosis can have a downside for
the bacteria's human hosts. When people overuse antibiotics or consume "Western" diets rich in carbs, fats and sugar, the gut microbiome can
be altered in ways that promote disease.

Indeed, it now appears that the increased risks of obesity, diabetes, hypertension and atherosclerosis that are conferred by the Western diet
are due in part to adverse changes in the microbiome.

That recognition has led researchers to look for ways to remodel the microbiome, with the goal of rolling back those adverse changes to
restore good health. Ghadiri and his team have been working on a method
that involves delivering small molecules to kill or slow the growth of
bad gut bacteria without affecting good gut bacteria.

"Our approach, using small molecules called cyclic peptides, is inspired
by nature," says co-senior author Luke Leman, PhD, an assistant professor
in the Department of Chemistry at Scripps Research. "Our cells naturally
use a diverse collection of molecules including antimicrobial peptides
to regulate our gut microbe populations." A screening system to identify microbiome remodelers


========================================================================== Prior to the experiments, the team already had a small collection of
cyclic peptides that had been made using chemistry techniques. For the
study, they set up a screening system to determine if any of those
peptides could beneficially remodel the mammalian gut microbiome by
suppressing undesirable gut bacterial species.

Using mice that are genetically susceptible to high cholesterol, they
fed the animals a Western-type diet that swiftly and reliably produces
high blood cholesterol and atherosclerosis, as well as adverse shifts
in the gut microbiome. The researchers then sampled the animals' gut
contents and applied a different cyclic peptide to each sample. A day
later, they sequenced the bacterial DNA in the samples to determine
which peptides had shifted the gut bacteriome in the desired direction.

The scientists soon identified two peptides that had significantly slowed
the growth of undesirable gut bacteria, shifting the species balance
closer to what is seen in mice that are fed a healthier diet. Using
these peptides to treat atherosclerosis-prone mice that were eating a
high-fat Western diet, they found striking reductions in the animals'
blood levels of cholesterol compared to untreated mice -- about 36 percent after two weeks of treatment. They also found that after 10 weeks, the atherosclerotic plaques in the arteries of the treated mice were about
40 percent reduced in area, compared to those in untreated mice.

"These were really remarkable effects," Ghadiri says.

The cyclic peptides used in the study apparently interact with the outer membranes of certain bacterial cells in ways that slow or stop the cells' growth. Ghadiri and his team have been researching these peptides for
years and have put together a set of dozens that show no toxicity to the
cells of mammals. The molecules also transit through the gut without
entering the bloodstream. In the study, the peptides were delivered
to the mice in drinking water and were not associated with any adverse
side effects.

Cheered by the proof-of-principle demonstration, the researchers are
now testing their peptides in mice that model diabetes, another common condition that has been linked to an unhealthy microbiome.


========================================================================== Story Source: Materials provided by Scripps_Research_Institute. Note:
Content may be edited for style and length.


========================================================================== Journal Reference:
1. Poshen B. Chen, Audrey S. Black, Adam L. Sobel, Yannan Zhao, Purba
Mukherjee, Bhuvan Molparia, Nina E. Moore, German R. Aleman Muench,
Jiejun Wu, Weixuan Chen, Antonio F. M. Pinto, Bruce E. Maryanoff,
Alan Saghatelian, Pejman Soroosh, Ali Torkamani, Luke J. Leman,
M. Reza Ghadiri. Directed remodeling of the mouse gut microbiome
inhibits the development of atherosclerosis. Nature Biotechnology,
2020; DOI: 10.1038/ s41587-020-0549-5 ==========================================================================

Link to news story: https://www.sciencedaily.com/releases/2020/06/200615140921.htm

--- up 20 weeks, 6 days, 2 hours, 34 minutes
* Origin: -=> Castle Rock BBS <=- Now Husky HPT Powered! (1337:3/111)